Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
2.
J Neurol ; 264(7): 1454-1464, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28631129

ABSTRACT

Management of Parkinson's disease (PD) using deep brain stimulation (DBS) requires complex care in specialized, multidisciplinary centers. A well-organized, efficient patient flow is crucial to ensure that eligible patients can quickly access DBS. Delays or inefficiencies in patient care may impact a center's ability to meet demand, creating a capacity bottleneck. Analysis of the current practices within a center may help identify areas for improvement. After external audit of the DBS workflow of the Lyon Neurological Hospital and comparison with other European centers, manageable steps were suggested to restructure the care pathway. Propositions of the audit comprised, for example: (1) directly admitting referred patients to hospital, without a prior neurological outpatient visit and (2) including the preoperative anesthesia consultation in the hospital stay 1 month before surgery, not separately. This reorganization (between 2013 and 2016) was performed without increases in hospital medical resources or costs. The time from patients' first referral to surgery was reduced (from 22 to 16 months; p = 0.033), as was the number of pre- and postoperative patient visits (11-5; p = 0.025) and the total cumulative length of in-hospital stay (20.5-17.5 nights; p = 0.02). Ultimately, the total number of PD consultations increased (346-498 per year), as did the number of DBS implants per year (32-45 patients). In this single center experience, restructuring the DBS care pathway allowed a higher number of PD patients to benefit from DBS therapy, with a shorter waiting time and without decreasing the quality of care.


Subject(s)
Critical Pathways , Deep Brain Stimulation , Parkinson Disease/therapy , Clinical Audit , Critical Pathways/economics , Deep Brain Stimulation/economics , Humans , Parkinson Disease/economics , Time Factors
3.
Hum Vaccin Immunother ; 11(5): 1165-72, 2015.
Article in English | MEDLINE | ID: mdl-25874807

ABSTRACT

Maternal immunization is an important strategy to prevent severe morbidity and mortality in mothers and their offspring. This study aimed to identify whether new parents were following immunization recommendations prior to pregnancy, during pregnancy, and postnatally. A cross-sectional survey was conducted by a questionnaire administered antenatally to pregnant women attending a maternity hospital with a follow-up telephone interview at 8-10 weeks post-delivery. Factors associated with uptake of pertussis vaccination within the previous 5 y or postnatally and influenza vaccination during pregnancy were explored using log binomial regression models. A total of 297 pregnant women completed the questionnaire. For influenza vaccine, 20.3% were immunized during pregnancy and 3.0% postnatally. For pertussis vaccine, 13.1% were vaccinated within 5 y prior to pregnancy and 31 women received the vaccine postnatally, 16 (51.6%) received the vaccine >4 weeks after delivery. Receiving a recommendation from a healthcare provider (HCP) was an independent predictor for receipt of both pertussis (RR 2.07, p < 0.001) and influenza vaccine (RR 2.26, p = 0.001). Non-English speaking mothers were significantly less likely to have received pertussis vaccination prior to pregnancy or postnatally (RR 0.24, p = 0.011). Multiparous pregnant women were less likely to have received an influenza vaccine during their current pregnancy (p = 0.015). Uptake of pregnancy related immunization is low and likely due to poor knowledge of availability, language barriers and lack of recommendations from HCPs. Strategies to improve maternal vaccine uptake should include education about recommended vaccines for both HCPs and parents and written information in a variety of languages.


Subject(s)
Disease Transmission, Infectious/prevention & control , Immunization/methods , Influenza Vaccines/administration & dosage , Influenza, Human/prevention & control , Pertussis Vaccine/administration & dosage , Whooping Cough/prevention & control , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Immunization/statistics & numerical data , Interviews as Topic , Pregnancy , Surveys and Questionnaires , Young Adult
5.
J Comp Pathol ; 147(2-3): 391-6, 2012.
Article in English | MEDLINE | ID: mdl-22520807

ABSTRACT

Southern sea otters (Enhydra lutris nereis) are threatened marine mammals that belong to the family Mustelidae and are native to the coast of Central California. Neoplasia is reported infrequently in sea otters. An adult female free-ranging southern sea otter was found alive at Pebble Beach, Monterey County, California, on January 1st, 1994 and died soon after capture. The carcass was submitted to the US Geological Survey - National Wildlife Health Center for necropsy examination. Grossly, a mass with rubbery texture was firmly attached to the left maxillary region of the skull and the nasopharynx was occluded by soft neoplastic tissue. Post-mortem skull radiographs showed an oval, smoothly marginated mineralized opaque mass centered on the left maxilla, extending from the canine tooth to caudal to the molar and replacing portions of the zygomatic arch and palatine and temporal bones. The majority of the mass protruded laterally from the maxilla and was characterized by central homogeneous mineral opacity. Microscopically, the mass was characterized by fully differentiated lamellar non-osteonal bone that expanded beyond the margins of the adjacent normal osteonal bone. Sections of the nasopharyngeal mass were comprised of moderately pleomorphic cells with bony stroma. Gross, microscopical and radiological findings were compatible with maxillary osteosarcoma with concurrent osteoma.


Subject(s)
Maxillary Neoplasms/veterinary , Neoplasms, Multiple Primary/veterinary , Osteoma/veterinary , Osteosarcoma/veterinary , Otters , Animals , Fatal Outcome , Female , Maxillary Neoplasms/diagnostic imaging , Maxillary Neoplasms/pathology , Neoplasms, Multiple Primary/diagnostic imaging , Neoplasms, Multiple Primary/pathology , Osteoma/diagnostic imaging , Osteoma/pathology , Osteosarcoma/diagnostic imaging , Osteosarcoma/pathology , Radiography
6.
Int J Parasitol ; 41(11): 1139-47, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21802422

ABSTRACT

Little is known of the genetic diversity of Toxoplasma gondii circulating in wildlife. In the present study wild animals, from the USA were examined for T. gondii infection. Tissues of naturally exposed animals were bioassayed in mice for isolation of viable parasites. Viable T. gondii was isolated from 31 animals including, to our knowledge for the first time, from a bald eagle (Haliaeetus leucocephalus), five gray wolves (Canis lupus), a woodrat (Neotoma micropus), and five Arctic foxes (Alopex lagopus). Additionally, 66 T. gondii isolates obtained previously, but not genetically characterised, were revived in mice. Toxoplasma gondii DNA isolated from these 97 samples (31+66) was characterised using 11 PCR-restriction fragment length polymorphism (RFLP) markers (SAG1, 5'- and 3'-SAG2, alt.SAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1 and Apico). A total of 95 isolates were successfully genotyped. In addition to clonal Types II, and III, 12 different genotypes were found. These genotype data were combined with 74 T. gondii isolates previously characterised from wildlife from North America and a composite data set of 169 isolates comprised 22 genotypes, including clonal Types II, III and 20 atypical genotypes. Phylogenetic network analysis showed limited diversity with dominance of a recently designated fourth clonal type (Type 12) in North America, followed by the Type II and III lineages. These three major lineages together accounted for 85% of strains in North America. The Type 12 lineage includes previously identified Type A and X strains from sea otters. This study revealed that the Type 12 lineage accounts for 46.7% (79/169) of isolates and is dominant in wildlife of North America. No clonal Type I strain was identified among these wildlife isolates. These results suggest that T. gondii strains in wildlife from North America have limited diversity, with the occurrence of only a few major clonal types.


Subject(s)
Toxoplasma/genetics , Toxoplasma/isolation & purification , Toxoplasmosis, Animal/epidemiology , Toxoplasmosis, Animal/parasitology , Animals , Animals, Domestic/parasitology , Animals, Wild/parasitology , Cats , Genetic Variation , Genotype , Mice , Molecular Sequence Data , North America , Phylogeny , Prevalence , Rodentia , Swine , Toxoplasma/classification
7.
Vet Parasitol ; 183(1-2): 156-9, 2011 Dec 29.
Article in English | MEDLINE | ID: mdl-21782345

ABSTRACT

Sarcocystis neurona is an important cause of fatal disease in sea otters in the USA. Encephalitis is the predominant lesion and parasites are confined to the central nervous system and muscles. Here we report retinochoroiditis in a sea otter (Enhydra lutris kenyoni) found dead on Copalis Beach, WA, USA. Salient lesions were confined to the brain and eye. Multifocal nonsuppurative meningoencephalitis was present in the cerebrum and cerebellum associated with S. neurona schizonts. The retina of one eye had a focus of inflammation that contained numerous S. neurona schizonts and merozoites. The focus extended from the retinal pigment epithelium inward through all layers of the retina, but inflammation was most concentrated at the inner surface of the tapetum and the outer retina. The inner and outer nuclear layers of the retina were disorganized and irregular at the site of inflammation. There was severe congestion and mild hemorrhage in the choroid, and mild hemorrhage into the vitreous body. Immunohistochemistry with S. neurona-specific polyclonal rabbit antibodies stained schizonts and merozoites. To our knowledge this is the first report of S. neurona-associated retinochoroiditis in any naturally infected animal.


Subject(s)
Brain/parasitology , Chorioretinitis/veterinary , Otters/parasitology , Sarcocystis/immunology , Sarcocystosis/veterinary , Animals , Antibodies, Protozoan , Brain/pathology , Chorioretinitis/parasitology , Chorioretinitis/pathology , Eye/parasitology , Eye/pathology , Fatal Outcome , Female , Immunohistochemistry/veterinary , Muscles/parasitology , Rabbits , Sarcocystis/isolation & purification , Sarcocystosis/parasitology , Sarcocystosis/pathology , Seawater , United States
8.
Dis Markers ; 27(5): 193-201, 2009.
Article in English | MEDLINE | ID: mdl-20037206

ABSTRACT

BACKGROUND: The association of DLG5 R30Q with IBD has been replicated in several populations, but is not statistically significant in others. We studied the incidence of DLG5 alleles in a population of IBD patients from Pennsylvania. METHODS: DLG5 R30Q (rs1248696) and G1066G (rs1248634) were analyzed with PCR-based RFLP methods in a total of 521 subjects, that included 105 individuals with IBD and 139 without IBD from a familial IBD registry, 107 with sporadic IBD, and 170 unrelated healthy controls. R30Q was further analyzed with SNPlex Genotyping System in 473 samples. RESULTS: RFLP genotyping data showed that, DLG5 R30Q was significantly associated with IBD overall (p=0.006), and separately with CD (p=0.009) and UC (p=0.024). The association of R30Q with IBD was entirely due to a male-associated effect (male vs female p=0.015 vs 0.241 (IBD), p=0.024 vs 0.190 (CD), and p=0.019 vs 0.575 (UC)). The frequency of the A allele carriage was elevated in both affected and unaffected members in the familial IBD cohort compared to healthy controls (p=0.037). In the family pedigrees, we observed differences in the expression of IBD in individuals carrying the A allele between families. CONCLUSIONS: In the studied population, DLG5 R30Q was associated with all forms of IBD. An elevated presence of the R30Q variant was observed in all members of a familial IBD registry. This association of the R30Q variant with IBD was male-specific.


Subject(s)
Biomarkers/blood , Inflammatory Bowel Diseases/genetics , Membrane Proteins/genetics , Tumor Suppressor Proteins/genetics , Base Sequence , Case-Control Studies , DNA Primers , Female , Genotype , Humans , Male , Pedigree , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length
9.
Vet Parasitol ; 152(1-2): 8-15, 2008 Mar 25.
Article in English | MEDLINE | ID: mdl-18243561

ABSTRACT

Sarcocystis neurona is an important cause of neurological disease in horses (equine protozoal myeloencephalitis, EPM) and sea otters in the United States. In addition, EPM-like disease has been diagnosed in several other land and marine mammals. Opossums are its only definitive hosts. Little genetic diversity among isolates of S. neurona from different hosts has been reported. Here, we used 11 microsatellites to characterize S. neurona DNA isolated from natural infections in 22 sea otters (Enhydra lutris) from California and Washington and in 11 raccoons (Procyon lotor) and 1 striped skunk (Mephitis mephitis) from Wisconsin. By jointly analyzing these 34 isolates with 26 isolates previously reported, we determined that geographic barriers may limit S. neurona dispersal and that only a limited subset of possible parasite genotypes may have been introduced to recently established opossum populations. Moreover, our study confirms that diverse intermediate hosts share a common infection source, the opossum (Didelphis virginiana).


Subject(s)
Genetic Variation , Mephitidae/parasitology , Otters/parasitology , Raccoons/parasitology , Sarcocystis/genetics , Sarcocystosis/veterinary , Animals , Brain/parasitology , California , Central Nervous System Protozoal Infections/parasitology , Central Nervous System Protozoal Infections/transmission , Central Nervous System Protozoal Infections/veterinary , Cluster Analysis , DNA, Protozoan/chemistry , DNA, Protozoan/genetics , Disease Reservoirs/parasitology , Disease Reservoirs/veterinary , Encephalomyelitis/parasitology , Encephalomyelitis/veterinary , Host-Parasite Interactions , Microsatellite Repeats , Phylogeny , Sarcocystis/classification , Sarcocystosis/parasitology , Tongue/parasitology , Washington
10.
Vet Parasitol ; 151(2-4): 125-32, 2008 Feb 14.
Article in English | MEDLINE | ID: mdl-18155841

ABSTRACT

Sea otters (Enhydra lutris) have been reported to become infected with Toxoplasma gondii and at times succumb to clinical disease. Here, we determined genotypes of 39 T. gondii isolates from 37 sea otters in two geographically distant locations (25 from California and 12 from Washington). Six genotypes were identified using 10 PCR-RFLP genetic markers including SAG1, SAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1, and Apico, and by DNA sequencing of loci SAG1 and GRA6 in 13 isolates. Of these 39 isolates, 13 (33%) were clonal Type II which can be further divided into two groups at the locus Apico. Two of the 39 isolates had Type II alleles at all loci except a Type I allele at locus L358. One isolate had Type II alleles at all loci except the Type I alleles at loci L358 and Apico. One isolate had Type III alleles at all loci except Type II alleles at SAG2 and Apico. Two sea otter isolates had a mixed infection. Twenty-one (54%) isolates had an unique allele at SAG1 locus. Further genotyping or DNA sequence analysis for 18 of these 21 isolates at loci SAG1 and GRA6 revealed that there were two different genotypes, including the previously identified Type X (four isolates) and a new genotype named Type A (14 isolates). The results from this study suggest that the sea otter isolates are genetically diverse.


Subject(s)
Genetic Variation , Otters/parasitology , Toxoplasma/genetics , Toxoplasmosis, Animal/parasitology , Animals , Antibodies, Protozoan/blood , California , Genes, Protozoan/genetics , Genotype , Mice , Polymerase Chain Reaction/veterinary , Polymorphism, Restriction Fragment Length , Toxoplasma/classification , Toxoplasma/isolation & purification , Toxoplasma/pathogenicity , Washington
11.
J Comp Pathol ; 137(2-3): 102-21, 2007.
Article in English | MEDLINE | ID: mdl-17692867

ABSTRACT

Protozoal meningoencephalitis is considered to be an important cause of mortality in the California sea otter (Enhydra lutris). Thirty nine of 344 (11.3%) California (CA) and Washington state (WA) sea otters examined from 1985 to 2004 had histopathological evidence of significant protozoal meningoencephalitis. The aetiological agents and histopathological changes associated with these protozoal infections are described. The morphology of the actively multiplicative life stages of the organisms (tachyzoites for Toxoplasma gondii and merozoites for Sarcocystis neurona) and immunohistochemical labelling were used to identify infection with S. neurona (n=22, 56.4%), T. gondii (n=5, 12.8%) or dual infection with both organisms (n=12, 30.8%). Active S. neurona was present in all dual infections, while most had only the latent form of T. gondii. In S. neurona meningoencephalitis, multifocal to diffuse gliosis was widespread in grey matter and consistently present in the molecular layer of the cerebellum. In T. gondii meningoencephalitis, discrete foci of gliosis and malacia were more widely separated, sometimes incorporated pigment-laden macrophages and mineral, and were found predominantly in the cerebral cortex. Quiescent tissue cysts of T. gondii were considered to be incidental and not a cause of clinical disease and mortality. Protozoal meningoencephalitis was diagnosed more frequently in the expanding population of WA sea otters (10 of 31, 32.3%) than in the declining CA population (29 of 313, 9.3%). Among sea otters with protozoal meningoencephalitis, those that had displayed neurological signs prior to death had active S. neurona encephalitis, supporting the conclusion that S. neurona is the most significant protozoal pathogen in the central nervous system of sea otters.


Subject(s)
Brain/pathology , Brain/parasitology , Central Nervous System Protozoal Infections/veterinary , Otters/parasitology , Sarcocystosis/veterinary , Toxoplasmosis, Animal/pathology , Animals , Antibodies, Protozoan/metabolism , Antigens, Protozoan/metabolism , Brain/metabolism , Cells, Cultured , Central Nervous System Protozoal Infections/metabolism , Central Nervous System Protozoal Infections/pathology , Heart/parasitology , Lung/metabolism , Lung/parasitology , Lung/pathology , Muscle, Skeletal/metabolism , Muscle, Skeletal/parasitology , Muscle, Skeletal/pathology , Myocardium/metabolism , Myocardium/pathology , Retrospective Studies , Sarcocystis/immunology , Sarcocystis/pathogenicity , Sarcocystosis/metabolism , Sarcocystosis/pathology , Toxoplasma/immunology , Toxoplasma/pathogenicity , Toxoplasmosis, Animal/metabolism
12.
Dis Markers ; 22(5-6): 277-91, 2006.
Article in English | MEDLINE | ID: mdl-17264398

ABSTRACT

BPD_28D (O2 dependency at 28 days of life) and BPD_36W (O2 dependency at 36 wks post-menstrual age) are diseases of prematurely born infants exposed to mechanical ventilation and/or oxygen supplementation. In order to determine whether genetic variants of surfactant proteins (SPs-A, B, C, and D) and SP-B-linked microsatellite markers are risk factors in BPD, we performed a family based association study using a Greek study group of 71 neonates (<30 wks gestational age) from 60 families with, 52 BPD_28D and 19 BPD_36W, affected infants. Genotyping was performed using newly designed pyrosequencing assays and previously published methods. Associations between genetic variants of SPs and BPD subgroups were determined using Transmission Disequilibrium Test (TDT) and Family Based Association Test (FBAT). Significant associations (p

Subject(s)
Bronchopulmonary Dysplasia/genetics , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide , Pulmonary Surfactant-Associated Proteins/genetics , Alleles , Female , Genetic Markers , Genotype , Haplotypes , Humans , Infant, Newborn , Male , Microsatellite Repeats , Pulmonary Surfactant-Associated Protein A/genetics , Pulmonary Surfactant-Associated Protein B/genetics , Pulmonary Surfactant-Associated Protein C/genetics , Pulmonary Surfactant-Associated Protein D/genetics , Sequence Analysis, DNA
13.
Neuroscience ; 134(1): 1-8, 2005.
Article in English | MEDLINE | ID: mdl-15951120

ABSTRACT

Rats were given bilateral lesions of the motor cortex on the tenth day of life, and then received a daily subcutaneously injection of either basic fibroblast growth factor (FGF-2) or vehicle for 7 consecutive days. In adulthood, they were trained and assessed on a skilled forelimb reaching task. Although all lesion groups were impaired at skilled reaching, the postnatal day 10-lesioned group that received FGF-2 was less impaired than the lesion group that received the vehicle. Furthermore, the lesioned rats that received FGF-2 showed a filling of the lesion cavity with tissue, whereas the lesioned vehicle-treated rats still had a prominent lesion cavity. The functionality of the tissue filling the cavity, tissue surrounding it, and tissue from the motor cortex (in control rats) was assessed using intracortical microstimulation, and showed that stimulation of some sites from the filled cavity could evoke movement. The rats were perfused and processed for Golgi-Cox staining. Medium spiny neurons from the striatum were drawn and analyzed, and the results suggest that postnatal day 10 lesions of the motor cortex induced an increase in the length and complexity of these cells compared with those of non-lesioned rats. Our results suggest that FGF-2 may play an important role in recovery from early brain damage.


Subject(s)
Brain Injuries/drug therapy , Fibroblast Growth Factor 2/administration & dosage , Motor Cortex/drug effects , Recovery of Function/drug effects , Analysis of Variance , Animals , Animals, Newborn , Brain/pathology , Brain Injuries/pathology , Brain Mapping , Dendritic Spines/pathology , Electric Stimulation/methods , Male , Motor Cortex/injuries , Motor Cortex/pathology , Movement/drug effects , Movement/radiation effects , Neurons/pathology , Organ Size/drug effects , Organ Size/physiology , Psychomotor Performance/drug effects , Psychomotor Performance/physiology , Rats , Rats, Long-Evans
14.
Pediatr Cardiol ; 26(4): 460-3, 2005.
Article in English | MEDLINE | ID: mdl-15690240

ABSTRACT

A 6-year-old girl presented with respiratory distress. Chest radiographs exhibited calcifications in the mediastinum. Further imaging revealed extensive cardiac calcifications on computed tomography of the chest. The laboratory parameters were consistent with findings of secondary hyperparathyroidism. Detailed review of her dietary history revealed a prolonged history of dietary deficiency of calcium and vitamin D. Treatment consisted of adequate daily replacement of calcium and ergocalciferol. On follow-up, her parathyroid hormone level was significantly reduced and substantially reduced cardiac calcifications were seen on echocardiogram. Pediatric cardiologists must be aware of this potentially fatal but treatable disease in children with cardiac calcifications unexplained by other causes.


Subject(s)
Calcinosis/etiology , Calcium, Dietary/blood , Calcium/deficiency , Cardiomyopathies/etiology , Hyperparathyroidism, Secondary/complications , Vitamin D Deficiency/complications , Calcinosis/blood , Calcinosis/drug therapy , Calcium/blood , Calcium, Dietary/therapeutic use , Cardiomyopathies/blood , Cardiomyopathies/drug therapy , Child , Ergocalciferols/therapeutic use , Female , Follow-Up Studies , Humans , Hyperparathyroidism, Secondary/blood , Hyperparathyroidism, Secondary/drug therapy , Vitamin D Deficiency/blood , Vitamin D Deficiency/drug therapy , Vitamins/therapeutic use
15.
Pediatr Cardiol ; 26(1): 104-6, 2005.
Article in English | MEDLINE | ID: mdl-15136901

ABSTRACT

Extrarenal involvement manifesting in the cardiovascular system is a rare but potentially fatal complication of hemolytic uremic syndrome (HUS). Current treatment is aimed at cardiovascular supportive measures while awaiting organ recovery. However, there are cases in which this recovery never occurs, and patients succumb secondary to heart failure. We report two cases of severe cardiac failure in children in the acute phase of HUS and the use of extracorporeal membrane oxygenation (ECMO) to support one patient to cardiac recovery. Clinicians should be aware of this potentially life-threatening cardiac involvement and should consider the use of ECMO for potentially salvageable children with HUS.


Subject(s)
Extracorporeal Membrane Oxygenation , Heart Failure/etiology , Heart Failure/therapy , Hemolytic-Uremic Syndrome/complications , Child, Preschool , Fatal Outcome , Female , Humans , Male
16.
Arch Environ Contam Toxicol ; 46(4): 542-50, 2004 May.
Article in English | MEDLINE | ID: mdl-15253053

ABSTRACT

We reviewed the U.S. Geological Survey National Wildlife Health Center (NWHC) mortality database from 1980 to 2000 to identify cases of poisoning caused by organophosphorus and carbamate pesticides. From the 35,022 cases from which one or more avian carcasses were submitted to the NWHC for necropsy, we identified 335 mortality events attributed to anticholinesterase poisoning, 119 of which have been included in earlier reports. Poisoning events were classified as confirmed (n = 205) when supported by findings of > or =50% inhibition of cholinesterase (ChE) activity in brain tissue and the detection of a specific pesticide in the gastrointestinal contents of one or more carcasses. Suspected poisonings (n = 130) were defined as cases where brain ChE activity was > or =50% inhibited or a specific pesticide was identified in gastrointestinal contents. The 335 avian mortality events occurred in 42 states. Washington, Virginia, and Ohio had the highest frequency of events, with 24 (7.2%), 21 (6.3%), and 20 (6.0%) events, respectively. A total of 8877 carcasses of 103 avian species in 12 orders was recovered. Because carcass counts underestimate total mortality, this represents the minimum actual mortality. Of 24 different pesticides identified, the most frequent were famphur (n = 59: 18%), carbofuran (n = 52; 15%), diazinon (n = 40; 12%), and fenthion (n = 17; 5.1%). Falconiformes were reported killed most frequently (49% of all die-offs) but Anseriformes were found dead in the greatest numbers (64% of 8877 found dead). The majority of birds reported killed by famphur were Passeriformes and Falconiformes, with the latter found dead in 90% of famphur-related poisoning events. Carbofuran and famphur were involved in mortality of the greatest variety of species (45 and 33, respectively). Most of the mortality events caused by diazinon involved waterfowl.


Subject(s)
Bird Diseases , Birds , Cholinesterase Inhibitors/poisoning , Pesticides/poisoning , Acetylcholinesterase/metabolism , Animals , Bird Diseases/chemically induced , Bird Diseases/enzymology , Bird Diseases/mortality , Brain/drug effects , Brain/enzymology , Brain/pathology , Poisoning/enzymology , Poisoning/mortality , Poisoning/veterinary , Retrospective Studies , United States/epidemiology
17.
Vet Parasitol ; 125(1-2): 131-5, 2004 Oct 28.
Article in English | MEDLINE | ID: mdl-24937884

ABSTRACT

This collection of abstracts provides an account of four presentations at the 19th International Conference of the World Association for the Advancement of Veterinary Parasitology (WAAVP)(held in New Orleans, LA, USA from 10­14 August 2003) in a symposium session on zoonotic protozoan parasites found in the marine environment and chaired by Ronald Fayer and David Lindsay.The focus was on three genera of parasites of veterinary and public health concern­Toxoplasma,Giardia, and Cryptosporidium with emphasis on their epidemiology in the marine environment.


Subject(s)
Aquatic Organisms/parasitology , Eukaryota/physiology , Parasitic Diseases/parasitology , Public Health , Zoonoses/parasitology , Animals , Humans
18.
Vet Parasitol ; 116(4): 275-96, 2003 Oct 30.
Article in English | MEDLINE | ID: mdl-14580799

ABSTRACT

Toxoplasma gondii, Neospora caninum, Sarcocystis neurona, and S. canis are related protozoans that can cause mortality in many species of domestic and wild animals. Recently, T. gondii and S. neurona were recognized to cause encephalitis in marine mammals. As yet, there is no report of natural exposure of N. caninum in marine mammals. In the present study, antibodies to T. gondii and N. caninum were assayed in sera of several species of marine mammals. For T. gondii, sera were diluted 1:25, 1:50, and 1:500 and assayed in the T. gondii modified agglutination test (MAT). Antibodies (MAT > or =1:25) to T. gondii were found in 89 of 115 (77%) dead, and 18 of 30 (60%) apparently healthy sea otters (Enhydra lutris), 51 of 311 (16%) Pacific harbor seals (Phoca vitulina), 19 of 45 (42%) sea lions (Eumetopias jubatus) [corrected] 5 of 32 (16%) ringed seals (Phoca hispida), 4 of 8 (50%) bearded seals (Erignathus barbatus), 1 of 9 (11.1%) spotted seals (Phoca largha), 138 of 141 (98%) Atlantic bottlenose dolphins (Tursiops truncatus), and 3 of 53 (6%) walruses (Odobenus rosmarus). For N. caninum, sera were diluted 1:40, 1:80, 1:160, and 1:320 and examined with the Neospora agglutination test (NAT) using mouse-derived tachyzoites. NAT antibodies were found in 3 of 53 (6%) walruses, 28 of 145 (19%) sea otters, 11 of 311 (3.5%) harbor seals, 1 of 27 (3.7%) sea lions, 4 of 32 (12.5%) ringed seals, 1 of 8 (12.5%) bearded seals, and 43 of 47 (91%) bottlenose dolphins. To our knowledge, this is the first report of N. caninum antibodies in any marine mammal, and the first report of T. gondii antibodies in walruses and in ringed, bearded, spotted, and ribbon seals. Current information on T. gondii-like and Sarcocystis-like infections in marine mammals is reviewed. New cases of clinical S. canis and T. gondii infections are also reported in sea lions, and T. gondii infection in an Antillean manatee (Trichechus manatus manatus).


Subject(s)
Cetacea/parasitology , Coccidiosis/veterinary , Neospora , Otters/parasitology , Sarcocystosis/veterinary , Seals, Earless/parasitology , Toxoplasmosis, Animal/epidemiology , Agglutination Tests/veterinary , Animals , Antibodies, Protozoan/blood , Coccidiosis/epidemiology , Coccidiosis/parasitology , Female , Male , Neospora/immunology , Neospora/isolation & purification , Sarcocystis/immunology , Sarcocystis/isolation & purification , Sarcocystosis/epidemiology , Sarcocystosis/parasitology , Seroepidemiologic Studies , Toxoplasma/immunology , Toxoplasma/isolation & purification , Toxoplasmosis, Animal/parasitology
19.
J Parasitol ; 89(2): 397-9, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12760665

ABSTRACT

The number of Sarcocystis species that infect sea otters (Enhydra lutris) is unknown. Sea otter tissues were recently shown to harbor sarcocysts of S. neurona and of unidentified species of Sarcocystis. Whereas sarcocysts of S. neurona have walls 1-3 microm thick with type 9 villar protrusions, ultrastructure of a distinct thin-walled sarcocyst (0.5-0.7 microm thick) lacking villar protrusions, but instead exhibiting minute type 1 undulations on the sarcocyst wall, is described in this report. Parasites characterized from a sea otter infection were inferred to be related to, but distinct from, other species belonging to Sarcocystis, based on sequencing and phylogenetic analysis of a portion of the beta subunit of the plastid-encoded RNA polymerase gene.


Subject(s)
Muscle, Skeletal/parasitology , Otters/parasitology , Sarcocystis/isolation & purification , Sarcocystosis/veterinary , Animals , DNA Primers , DNA, Protozoan/chemistry , DNA-Directed RNA Polymerases/genetics , Microscopy, Electron/veterinary , Muscle, Skeletal/ultrastructure , Phylogeny , Polymerase Chain Reaction/veterinary , Sarcocystis/classification , Sarcocystis/genetics , Sarcocystis/ultrastructure , Sarcocystosis/parasitology
20.
Vet Parasitol ; 97(4): 319-27, 2001 Jun 28.
Article in English | MEDLINE | ID: mdl-11390085

ABSTRACT

Dual Sarcocystis neurona and Toxoplasma gondii infection was observed in a Northern sea otter from Washington, USA. The animal was found stranded, convulsed, and died shortly thereafter. Encephalitis caused by both S. neurona and T. gondii was demonstrated in histological sections of brain. Immunohistochemical examination of sections with S. neurona specific antisera demonstrated developmental stages that divided by endopolygeny and produced numerous merozoites. PCR of brain tissue from the sea otter using primer pairs JNB33/JNB54 resulted in amplification of a 1100 bp product. This PCR product was cut in to 884 and 216 bp products by Dra I but was not cut by Hinf I indicating that it was S. neurona [J. Parasitol. 85 (1999) 221]. No PCR product was detected in the brain of a sea otter which had no lesions of encephalitis. Examination of brain sections using T. gondii specific antisera demonstrated tachyzoites and tissue cysts of T. gondii. The lesions induced by T. gondii suggested that the sea otter was suffering from reactivated toxoplasmosis. T. gondii was isolated in mice inoculated with brain tissue. A cat that was fed infected mouse brain tissue excreted T. gondii oocysts which were infective for mice. This is apparently the first report of dual S. neurona and T. gondii in a marine mammal.


Subject(s)
Otters/parasitology , Sarcocystosis/veterinary , Toxoplasma/isolation & purification , Toxoplasmosis, Animal/parasitology , Animals , Biological Assay , Brain/parasitology , Brain/pathology , Cats , DNA, Protozoan/chemistry , Fatal Outcome , Female , Immunohistochemistry/veterinary , Male , Mice , Mice, Inbred BALB C , Polymerase Chain Reaction , Sarcocystis/genetics , Sarcocystis/isolation & purification , Sarcocystosis/parasitology , Sarcocystosis/pathology , Toxoplasmosis, Animal/pathology , Washington
SELECTION OF CITATIONS
SEARCH DETAIL
...